Cargando…

Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS)

CONTEXT: Hypertension (HTN) is a well-known modifiable risk factor for cardiovascular disease (CVD), chronic kidney disease and mortality. Positive effects of blood pressure (BP) lowering for prevention of CVD and death have been documented in several meta-analyses of randomized controlled trials. E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdi, Hengameh, Amouzegar, Atieh, Tohidi, Maryam, Azizi, Fereidoun, Hadaegh, Farzad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289294/ https://www.ncbi.nlm.nih.gov/pubmed/30584437 http://dx.doi.org/10.5812/ijem.84769

Ejemplares similares

Tobacco Smoking: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Parizadeh, Donna, et al.
Publicado: (2018)

BMI variability and incident diabetes mellitus, Tehran Lipid and Glucose Study (TLGS)
por: Mehran, Ladan, et al.
Publicado: (2022)

Diabetes Mellitus: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2018)

Impact of 3-year changes in lipid parameters and their ratios on incident type 2 diabetes: Tehran lipid and glucose study
por: Khaloo, Pegah, et al.
Publicado: (2018)

Serum Lipids During 20 Years in the Tehran Lipid and Glucose Study: Prevalence, Trends and Impact on Non-Communicable Diseases
por: Baghbani-Oskouei, Aidin, et al.
Publicado: (2018)

Impact of 3-year changes in fasting insulin and insulin resistance indices on incident hypertension: Tehran lipid and glucose study
por: Baghbani-Oskouei, Aidin, et al.
Publicado: (2019)

The Hidden Link between Polycystic Ovary Syndrome and Kidney Stones: Finding from the Tehran Lipid and Glucose Study (TLGS)
por: Rostami Dovom, Marzieh, et al.
Publicado: (2023)

Validation of the Framingham hypertension risk score in a middle eastern population: Tehran lipid and glucose study (TLGS)
por: Koohi, Fatemeh, et al.
Publicado: (2021)

Gender differences in the impact of 3-year status changes of metabolic syndrome and its components on incident type 2 diabetes mellitus: a decade of follow-up in the Tehran Lipid and Glucose Study
por: Hadaegh, Farzad, et al.
Publicado: (2023)

Tehran Thyroid Study (TTS)
por: Amouzegar, Atieh, et al.
Publicado: (2018)

The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study
por: Barzegar, Niloofar, et al.
Publicado: (2020)

Socio-Demographic Determinants of Health-Related Quality of Life in Tehran Lipid and Glucose Study (TLGS)
por: Jalali-Farahani, Sara, et al.
Publicado: (2017)

Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2020)

Correction To: Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2020)

Trends of Obesity in 10-Years of Follow-up among Tehranian Children and Adolescents: Tehran Lipid and Glucose Study (TLGS)
por: HOSSEINPANAH, Farhad, et al.
Publicado: (2019)

Sex specific impact of different obesity phenotypes on the risk of incident hypertension: Tehran lipid and glucose study
por: Kabootari, Maryam, et al.
Publicado: (2019)

Incidence of obesity and its predictors in children and adolescents in 10 years of follow up: Tehran lipid and glucose study (TLGS)
por: Barzin, Maryam, et al.
Publicado: (2018)

The relationship between glucose intolerance status and risk of hospitalization during two decades of follow-up: Tehran lipid and glucose study
por: Rasooli, Rahele, et al.
Publicado: (2022)

Serum Lipids and Cardiovascular Disease Mortality in Iranian Population: Joint Modeling of Longitudinal and Survival Data in Tehran Lipid and Glucose Study (TLGS) Cohort
por: Pahlavanzade, Bagher, et al.
Publicado: (2019)

Insulin Monotherapy Versus Insulin Combined with Other Glucose-Lowering Agents in Type 2 Diabetes: A Narrative Review
por: Abdi, Hengameh, et al.
Publicado: (2018)

Prevalence of Subclinical Hypothyroidism in Chronic Kidney Disease in a Population-based Study: Tehran Thyroid Study
por: Kazempour-Ardebili, Sara, et al.
Publicado: (2021)

Sex differences in the association between diabetes and hypertension and the risk of stroke: cohort of the Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2022)

Trend of lipid and thyroid function tests in adults without overt thyroid diseases: A cohort from Tehran thyroid study
por: Ahi, Salma, et al.
Publicado: (2019)

Correction: Trend of lipid and thyroid function tests in adults without overt thyroid diseases: A cohort from Tehran thyroid study
por: Ahi, Salma, et al.
Publicado: (2019)

BMI category-specific waist circumference thresholds based on cardiovascular disease outcomes and all-cause mortality: Tehran lipid and glucose study (TLGS)
por: Seyedhoseinpour, Amirhosein, et al.
Publicado: (2023)

The impact of general and central obesity for all-cause hospitalization among Iranian adults: a 20 year follow-up-results from the TLGS cohort
por: Ramezankhani, Azra, et al.
Publicado: (2023)

Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study
por: Kabootari, Maryam, et al.
Publicado: (2020)

Secular trends in serum lipid levels of a Middle Eastern adult population; 10 years follow up in Tehran lipid and glucose study
por: Kheirandish, Masoumeh, et al.
Publicado: (2014)

The association of priori and posteriori dietary patterns with the risk of incident hypertension: Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2021)

The association of the age, period, and birth cohort with 15-year changes in body mass index and waist circumference in adults: Tehran lipid and glucose study (TLGS)
por: Barzin, Maryam, et al.
Publicado: (2022)

Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2010)

Sex Differences in Cumulative Exposure to Metabolic Risk Factors Before Hypertension Onset: The Cohort of the Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2021)

Investigating the prevalence of primary thyroid dysfunction in obese and overweight individuals: Tehran thyroid study
por: Mahdavi, Mahdi, et al.
Publicado: (2021)

Association between Physical Activity and Metabolic Risk Factors in Adolescents: Tehran Lipid and Glucose Study
por: Fam, Bita, et al.
Publicado: (2013)

Overweight and Obesity: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Barzin, Maryam, et al.
Publicado: (2018)

The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study
por: Amouzegar, Atieh, et al.
Publicado: (2017)

Sex specific trajectories of central adiposity, lipid indices, and glucose level with incident hypertension: 12 years Follow-up in Tehran lipid and glucose study
por: Ahanchi, Noushin Sadat, et al.
Publicado: (2021)

Antithyroid Drugs
por: Abdi, Hengameh, et al.
Publicado: (2019)

Efficacy of low-dose methimazole in control of multiple relapses of Graves’ hyperthyroidism: a case report
por: Azizi, Fereidoun, et al.
Publicado: (2021)

Control of Graves’ hyperthyroidism with very long-term methimazole treatment: a clinical trial
por: Azizi, Fereidoun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3ubok20d8ba7nu71p97jtcqcuq